Gillian C. Ivers-Read

2019

In 2019, Gillian C. Ivers-Read earned a total compensation of $2.6M as EVP and Chief Regulatory Officer at Clovis Oncology, a 50% increase compared to previous year.

Compensation breakdown

Bonus$221,354
Option Awards$380,788
Salary$464,692
Stock Awards$1,544,691
Other$27,368
Total$2,638,893

Ivers-Read received $1.5M in stock awards, accounting for 59% of the total pay in 2019.

Ivers-Read also received $221.4K in bonus, $380.8K in option awards, $464.7K in salary and $27.4K in other compensation.

Rankings

In 2019, Gillian C. Ivers-Read's compensation ranked 4,632nd out of 13,971 executives tracked by ExecPay. In other words, Ivers-Read earned more than 66.8% of executives.

ClassificationRankingPercentile
All
4,632
out of 13,971
67th
Division
Manufacturing
1,728
out of 5,695
70th
Major group
Chemicals And Allied Products
605
out of 2,194
72nd
Industry group
Drugs
509
out of 1,880
73rd
Industry
Pharmaceutical Preparations
383
out of 1,392
73rd

Pay ratio

Gillian C. Ivers-Read's Pay$2,638,893
Median Employee's Pay$262,806
Pay Ratio

10

to 1

In 2019, the annual total compensation of Gillian C. Ivers-Read was $2,638,893.

The annual total compensation of the median employee at Clovis Oncology was $262,806.

The ratio of Gillian C. Ivers-Read's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 24, 2020.

Ivers-Read's colleagues

We found four more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2019.

2019

Patrick Mahaffy

Clovis Oncology

Chief Executive Officer

2019

Paul Gross

Clovis Oncology

General Counsel

2019

Daniel Muehl

Clovis Oncology

Chief Financial Officer

2019

Lindsey Rolfe

Clovis Oncology

Chief Medical Officer

News

You may also like